0 Kommentare
0 Geteilt
221 Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
Radiofrequency Ablation Systems Market: Insights, Key Players, and Growth AnalysisAccording to the latest report published by Data Bridge Market Research, the Radiofrequency Ablation Systems Market CAGR Value The global radiofrequency ablation systems market size was valued at USD 3.65 billion in 2024 and is projected to reach USD 6.60 billion by 2032, with a CAGR of 7.69% during the forecast period of 2025 to 2032. This Radiofrequency Ablation...0 Kommentare 0 Geteilt 93 Ansichten 0 Bewertungen
-
Electrophysiology Devices Market Insights 2025–2034 | Growth from US$ 11.09B to US$ 26.61BThe Electrophysiology industry centers on technologies that analyze and correct abnormal heart rhythms. From diagnostic mapping tools to ablation devices, it plays a vital role in managing arrhythmias and enhancing cardiovascular care. Electrophysiology Market Growth Analysis The Electrophysiology Market is projected to grow significantly from US$ 11.09 billion in 2025 to US$ 26.61...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen1
-
Global Tissue Ablation Market Size, Share & Growth Forecast 2025–2031 | CAGR 7.2%According to a newly published market research report by 24LifeSciences, global glycated hemoglobin testing market was valued at USD 322 million in 2024 and is projected to reach USD 530 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031. Glycated hemoglobin (HbA1c) testing serves as the gold standard for diabetes management...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen
-
Global Tissue Ablation Market Size, Share & Growth Forecast 2025–2031 | CAGR 7.2%According to a newly published market research report by 24LifeSciences, global glycated hemoglobin testing market was valued at USD 322 million in 2024 and is projected to reach USD 530 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031. Glycated hemoglobin (HbA1c) testing serves as the gold standard for diabetes management...0 Kommentare 0 Geteilt 1KB Ansichten 0 Bewertungen